Sriram Ranga Anbil, MD
NPI 1083173165ActiveIndividual· Internal Medicine, Hematology & Oncology· Media, PA
Internal Medicine, Hematology & Oncology (MD) in Media, Pennsylvania, trained at University of Texas Medical School at San Antonio (class of 2019). Part D covered 23 prescriptions written in 2024, 65% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 16 companies reporting payments in 2025, $715.43 in all, mostly food and beverage.
Overview
| NPI | 1083173165 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Mar 18, 2019 |
| Last updated in NPPES | Sep 29, 2025 |
| Certified by provider | Sep 29, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | MD490295 | PA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Hematology/Oncology (PA) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 23 · 29 30-day fills |
|---|---|
| Patients | 17 |
| Total drug cost | $16,734 |
| Generic share | 65% of claims |
Education and affiliations
| Medical school | University of Texas Medical School at San Antonio |
|---|---|
| Graduation year | 2019 |
| Medicare specialty | Hematology/Oncology |
Medical group
- Alliance Cancer Specialists P.C.Sellersville, PA · 43 clinicians
Hospital affiliations
- Bryn Mawr HospitalBryn Mawr, PA
- Main Line Hospital LankenauWynnewood, PA
- Riddle Memorial HospitalMedia, PA
Industry payments (Open Payments)
- 2025$715.43 · 30 payments from 16 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $123.77 | 5 |
| Janssen Biotech, Inc. | $80.57 | 3 |
| Daiichi Sankyo Inc. | $72.30 | 3 |
| Novartis Pharmaceuticals Corporation | $62.17 | 3 |
| Bayer Healthcare Pharmaceuticals Inc. | $55.49 | 2 |
What the 2025 payments were for
- Food and Beverage$715.43 · 30 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records